ZS Associates

Last updated

ZS
Company typePrivate
IndustryConsulting, Analytics, AI
Founded1983;41 years ago (1983)
Headquarters Evanston, Illinois [1]
Area served
Worldwide
Key people
Pratap Khedkar (CEO) [2]

Prabhakant Sinha (Co-Founder) [2]

Andris Zoltners (Co-Founder) [2]
Number of employees
13000 [3]
Website www.zs.com

ZS Associates is a management consulting and professional services firm focusing on consulting, software, and technology. Headquartered in Evanston, Illinois, it provides healthcare, private equity, and technology services. [4] The firm was founded in 1983 by two professors at Northwestern University who developed sales force alignment models using the world’s first personal-computer-aided territory mapping system. [5]

Contents

The firm employs more than 12,000 employees [6] in 35 offices in North America, South America, Europe and Asia. [7]

The company was chosen by Forbes magazine as one of America’s best management and consulting firms in 2019  [8] and has been awarded for its company culture by Consulting magazine for several years in a row. [9] The Human Rights Campaign Foundation has also been recognized the company for earning 100 percent on their Annual Corporate Equality Index for LGBTQ workplace equality. [10]

History

ZS Associates was founded in 1983 by Andris (Andy) Zoltners, Frederic Esser Nemmers, Distinguished Professor Emeritus of Marketing at the Kellogg School of Management, [11] and Prabhakant (Prabha) Sinha, a former associate professor of marketing at the Kellogg School of Management. At Kellogg, Sinha and Zoltners developed a side business advising companies on sales and marketing, which evolved into ZS Associates. [12]

In 1982, Zoltners and Sinha presented their sales force sizing and territory alignment models to their academic colleagues, demonstrating the world’s first personal-computer-aided territory mapping system. [13] In 1983, Sinha joined Zoltners at Northwestern, and the pair founded ZS Associates in their off hours, offering companies increased sales force efficiency using their now-proven territory mapping software. In its first three years, ZS had helped eight of the 10 largest pharmaceutical companies in the world, including Pfizer, align territories and resize their sales forces. By that time, the 25-member team worked on 100 or more projects in a dozen countries—including the United States, Canada and many European countries.

Through the 1990s, ZS continued to develop its capabilities, [14] adding data warehousing, market forecasting, market research and analytical services for their clients. The firm also began sales force incentive compensation program auditing, design and implementation during these years.

Acquisitions

The company purchased the assets of BASES Pharmaceuticals Forecasting from Nielsen. [15]

In 2021, the company purchased Medullan, a company specializing in digital health and digital medicine strategies and solutions. [16] In 2022, Danish bioinformatics and systems biology company Intomics was acquired for an undisclosed amount. [17]

In February 2023, ZS purchased the intelligent design company Trials.ai. [18]

In June 2024, the company acquired Digital Additive. [19]

Industries

ZS operates as a strategic, long-term advisor to its clients, in the following incomplete list of industries: [20]

Related Research Articles

<span class="mw-page-title-main">AstraZeneca</span> British-Swedish pharmaceutical company

AstraZeneca plc (AZ) is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, United Kingdom. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.

<span class="mw-page-title-main">Kellogg School of Management</span> Business school of Northwestern University

The Kellogg School of Management at Northwestern University is the graduate business school of Northwestern University, a private research university in Evanston, Illinois. Founded in 1908 as the School of Commerce, Kellogg has the second-largest endowment of any business school.

Léger is the largest Canadian-owned market research and analytics company, with more than 600 employees in eight Canadian and US offices. The company was founded in 1986 by the father and son duo Marcel Léger, former environment minister of Quebec, and Jean-Marc Léger, economist. Previously, the company was known as Léger & Léger (1986–1996) and Léger Marketing (1996–2013).  It is now led solely by Jean-Marc Léger.

The pharmaceutical industry is one of the leading industries in the People's Republic of China, covering synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery. China has the second-largest pharmaceutical market in the world as of 2017 which is worth US$110 billion. China accounts for 20% of the world's population but only a small fraction of the global drug market. China's changing health-care environment is designed to extend basic health insurance to a larger portion of the population and give individuals greater access to products and services. Following the period of change, the pharmaceutical industry is expected to continue its expansion.

<span class="mw-page-title-main">Otsuka Pharmaceutical</span> Japanese pharmaceutical company

Otsuka Pharmaceutical Co., Ltd., abbreviated OPC, is a pharmaceutical company headquartered in Tokyo, Osaka and Naruto, Japan. The company was established August 10, 1964.

IMS Health was an American company that provided information, services and technology for the healthcare industry. IMS stood for Intercontinental Medical Statistics. It was the largest vendor of U.S. physician prescribing data. IMS Health was founded in 1954 by Bill Frohlich and David Dubow with Arthur Sackler having a hidden ownership stake. In 2010, IMS Health was taken private by TPG Capital, CPP Investment Board and Leonard Green & Partners. The company went public on April 4, 2014, and began trading on the NYSE under the symbol IMS. IMS Health was headquartered in Danbury, Connecticut.

Parexel International is an American provider of biopharmaceutical services. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process. It is the second largest clinical research organization in the world and has helped develop approximately 95% of the 200 top-selling biopharmaceuticals on the market today. The company publishes the annual Parexel R&D Statistical Sourcebook and operates the Parexel-Academy.

Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.

IQVIA, formerly Quintiles and IMS Health, Inc., is an American Fortune 500 and S&P 500 multinational company serving the combined industries of health information technology and clinical research. IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services. It has a network of more than 88,000 employees in more than 100 countries and a market capitalization of US$49 billion as of August 2021. As of 2023, IQVIA was reported to be one of the world's largest contract research organizations (CRO).

<span class="mw-page-title-main">Purdue Pharma</span> American pharmaceutical company (1892–2019 bankruptcy)

Purdue Pharma L.P., formerly the Purdue Frederick Company (1892–2019), was an American privately held pharmaceutical company founded by John Purdue Gray. It was sold to Arthur, Mortimer, and Raymond Sackler in 1952, and then owned principally by the Sackler family and their descendants.

<span class="mw-page-title-main">L.E.K. Consulting</span> International strategy consulting firm

L.E.K. Consulting is a global strategy consulting firm based in London and Boston. Founded in 1983 by three partners from Bain & Company, L.E.K. focuses on corporate strategy, marketing and sales, mergers and acquisitions, and operations. It provides expertise to life sciences and pharma, healthcare services, consumer products, financial services, energy and environment, media and entertainment, technology, travel and transport, industrials, and retail. The firm also has a strong private equity practice.

<span class="mw-page-title-main">Sun Pharma</span> Indian multinational pharmaceutical company

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals. 

Charterhouse Capital Partners is a London based private equity investment firm focused on investing in European mid-market companies valued between €200m and €1.5bn. The company targets investments across the services, healthcare, specialised industrials and consumer sectors.

Real Chemistry, formerly known as W2O Group, is a global health innovation company that utilizes artificial intelligence (AI) for its healthcare services. Founded by Jim Weiss in 2001, Real Chemistry is an American company with global offices in Europe and Canada.

<span class="mw-page-title-main">Lupin Limited</span> Indian multinational pharmaceutical company

Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.

“The incentive plan needs to align the salesperson’s activities with the firm’s objectives.” Toward that end, an effective plan may be based on the past (growth), the present, or the future.

Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States. One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem, the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid (GHB). In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness (EDS) in narcolepsy as well as obstructive sleep apnea (OSA). In 2022, it was announced that Axsome Therapeutics would be acquiring Sunosi from Jazz Pharmaceuticals.

Horizon Therapeutics plc was a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Horizon primarily markets products in the United States, which represented 97% of Horizon's 2019 worldwide sales. Amgen acquired the company in October 2023.

Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year.

Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises. Based in Bangalore, the company provides consulting in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics.

References

  1. ↑ "Bloomberg Business - ZS Associates Profile". Bloomberg. Retrieved February 25, 2015.
  2. 1 2 3 "ZS Leadership Team" . Retrieved March 9, 2015.
  3. ↑ "ZS has 13,000+ professionals in more than 35 offices worldwide". www.zs.com. Retrieved August 9, 2023.
  4. ↑ Viorel, Paul (October 9, 2024). "ZS Associates at Operations Calling: Embracing Digital Transformation in the Life Sciences Industry". IIoT World. Retrieved December 10, 2024.
  5. ↑ Stott, Phil (2013). Vault Guide to the Top 50 Management and Strategy Consulting Firms. Infobase Learning. ISBN   978-1-58131-903-3.
  6. ↑ "ZS Website" . Retrieved August 24, 2021.
  7. ↑ "Contact ZS" . Retrieved July 20, 2019.
  8. ↑ "America's Best Management Consulting Firms". Forbes. Retrieved November 27, 2019.
  9. ↑ "The 2018 Best Firms to Work For". Consultingmag.com. Retrieved November 27, 2019.
  10. ↑ "ZS Earns 100 Percent on Human Rights Campaign Foundation's 2019 LGBTQ Workplace Equality Scorecard | ZS". www.zs.com. Retrieved November 27, 2019.
  11. ↑ "Evanston men win pharmaceutical industry honor, Evanston Now". Evanston Now Jun 2015. Retrieved March 9, 2015.
  12. ↑ "Lighting the way: Anita and Prabha Kant Sinha lead cultural shift in charitable scene, Crain's Chicago". Chicago Business article December 2011. Retrieved March 9, 2015.
  13. ↑ Stott, Phil (2013). Vault Guide to the Top 50 Management and Strategy Consulting Firms. Infobase Learning. ISBN   978-1-58131-903-3.
  14. ↑ "ZS Associates Firm Profile". Management Consulted. November 6, 2016. Retrieved November 26, 2019.
  15. ↑ "ZS acquires Nielsen BASES tools for pharma market forecasting". PharmaCommerce. January 5, 2018. Retrieved December 10, 2024.
  16. ↑ "ZS acquires digital health firm Medullan". www.consulting.us. July 8, 2021. Retrieved December 10, 2024.
  17. ↑ "ZS acquires leading Danish bioinformatics specialist". Accura. Retrieved December 10, 2024.
  18. ↑ "ZS to acquire Trials.ai to deliver pharmaceuticals faster". pharmaphorum. February 7, 2023. Retrieved December 10, 2024.
  19. ↑ "ZS acquires Salesforce specialist Digital Additive". www.consulting.us. June 12, 2024. Retrieved December 10, 2024.
  20. ↑ "Industries | Healthcare, Pharma, Insurance, Travel Analytics | ZS". www.zs.com. Retrieved November 29, 2019.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.